The expression of MIR-375 is associated with carcinogenesis in three subtypes of lung cancer

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Jin, Yi ^a,b   Liu, Yalan ^a   Zhang, Jin ^a   Huang, Wei ^c   Jiang, Hongni ^a   Hou, Yingyong ^a   Xu, Chen ^a   Zhai, Changwen ^a   Gao, Xue ^d   Wang, Shuyang ^a   Wu, Ying ^a   Zhu, Hongguang ^a,d   Lu, Shaohua ^a  

^a FUDAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ITPKB PROTEIN; JANUS KINASE 2; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MICRORNA 375; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; RYANODINE RECEPTOR 2; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; MICRORNA; MIRN375 MICRORNA, HUMAN; RNA; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ACSL3 GENE; ADULT; ARTICLE; CACNG2 GENE; CARCINOGENESIS; CCDC6 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CSNK2A1 GENE; DOWN REGULATION; EMBRYO; FEMALE; FZD8 GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ITGA10 GENE; ITPKB GENE; JAK2 GENE; JUND GENE; LAMC1 GENE; LRP5 GENE; LUCIFERASE ASSAY; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; MAP3K5 GENE; MICROARRAY ANALYSIS; MIDDLE AGED; NLK GENE; PDPK1 GENE; PIAS1 GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUNX1 GENE; RYR2 GENE; SMALL CELL LUNG CANCER; SP1 GENE; SQUAMOUS CELL LUNG CARCINOMA; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; AGED; BIOSYNTHESIS; CLASSIFICATION; LUNG TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM PROTEINS; RNA, NEOPLASM; SMALL CELL LUNG CARCINOMA;

EID: 84955608417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144187     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A cancer Journal for clinicians. 2011; 61(2): 69-90. doi: 10.3322/caac.20107 PMID: 21296855.
2. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Seminars in roentgenology. 2005; 40(2): 90-7. PMID: 15898407.
3. Miller YE. Pathogenesis of lung cancer: 100 year report. American Journal of respiratory cell and molecular biology. 2005; 33(3): 216-23. doi: 10.1165/rcmb.2005-0158OE PMID: 16107574; PubMed Central PMCID: PMC2715312.
4. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-97. PMID: 14744438.
5. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer cell. 2006; 9(3): 189-98. doi: 10.1016/j.ccr. 2006.01.025 PMID: 16530703.
6. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A, et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. The European respiratory Journal. 2009; 33 (2): 352-9. doi: 10.1183/09031936.00084108 PMID: 19010987.
7. Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, et al. The role of microRNA in human lung squamous cell carcinoma. Cancer genetics and cytoGenetics. 2010; 200(2): 127-33. doi: 10.1016/j. cancergencyto.2010.03.014 PMID: 20620595.
8. Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, et al. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. American Journal of respiratory and critical Care Medicine. 2012; 186(11): 1160-7. doi: 10.1164/rccm.201203-0534OC PMID: 23043084.
9. Wu H, Zhu S, Mo YY. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell research. 2009; 19(4): 439-48. doi: 10.1038/cr.2009.18 PMID: 19238171; PubMed Central PMCID: PMC2664859.
10. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: MiR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncology reports. 2010; 23(6): 1625-33. PMID: 20428818.
11. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, et al. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer. 2010; 116(24): 5637-49. doi: 10.1002/cncr.25488 PMID: 20737563; PubMed Central PMCID: PMC3940365.
12. Nishikawa E, Osada H, Okazaki Y, Arima C, Tomida S, Tatematsu Y, et al. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer research. 2011; 71 (19): 6165-73. doi: 10.1158/0008-5472.CAN-11-1020 PMID: 21856745.
13. Zhao H, Zhu L, Jin Y, Ji H, Yan X, Zhu X. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells. Acta biochimica et biophysica Sinica. 2012; 44(2): 177-82. doi: 10.1093/abbs/gmr110 PMID: 22172490.
14. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS biology. 2007; 5(8): E203. doi: 10.1371/Journal.pbio.0050203 PMID: 17676975; PubMed Central PMCID: PMC1925136.
15. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E, Walker MD. The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PloS one. 2009; 4(4): E5033. doi: 10.1371/Journal.pone.0005033 PMID: 19343226; PubMed Central PMCID: PMC2660411.
16. Yan JW, Lin JS, He XX. The emerging role of miR-375 in cancer. International Journal of cancer Journal international du cancer. 2014; 135(5): 1011-8. doi: 10.1002/ijc.28563 PMID: 24166096.
17. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut. 2012; 61(1): 33-42. doi: 10.1136/gutjnl-2011-300178 PMID: 21813472.
18. Li J, Li X, Li Y, Yang H, Wang L, Qin Y, et al. Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization. PloS one. 2013; 8(1): E53582. doi: 10.1371/Journal.pone.0053582 PMID: 23301089; PubMed Central PMCID: PMC3536738.
19. Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, et al. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes, chromosomes & cancer. 2012; 51(5): 473-9. doi: 10.1002/gcc.21934 PMID: 22302717; PubMed Central PMCID: PMC3547654.
20. Chang C, Shi H, Wang C, Wang J, Geng N, Jiang X, et al. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neuroscience letters. 2012; 531(2): 204-8. doi: 10.1016/j.neulet.2012.10.021 PMID: 23103713.
21. Dai X, Chiang Y, Wang Z, Song Y, Lu C, Gao P, et al. Expression levels of microRNA-375 in colorectal carcinoma. Molecular medicine reports. 2012; 5(5): 1299-304. doi: 10.3892/mmr.2012.815 PMID: 22377847.
22. Wang S, Wang L, Bayaxi N, Li J, Verhaegh W, Janevski A, et al. A microRNA panel to discriminate carcinomas from high-grade intraepithelial neoplasms in colonoscopy biopsy tissue. Gut. 2013; 62 (2): 280-9. doi: 10.1136/gutjnl-2011-301554 PMID: 22535378.
23. Hui AB, Bruce JP, Alajez NM, Shi W, Yue S, Perez-Ordonez B, et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clinical cancer research: An official Journal of the American Association for Cancer Research. 2011; 17(24): 7539-50. doi: 10.1158/1078-0432.CCR-11-2102 PMID: 22031094.
24. Harris T, Jimenez L, Kawachi N, Fan JB, Chen J, Belbin T, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. The American Journal of pathology. 2012; 180(3): 917-28. doi: 10.1016/j.ajpath. 2011.12.004 PMID: 22234174; PubMed Central PMCID: PMC3349885.
25. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2012; 31 (28): 3357-69. doi: 10.1038/onc.2011.500 PMID: 22056881.
26. Li Y, Jiang Q, Xia N, Yang H, Hu C. Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance. The Journal of international medical research. 2012; 40(5): 1662-9. PMID: 23206448.
27. de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer research. 2010; 70(22): 9175-84. doi: 10.1158/0008-5472.CAN-10-1318 PMID: 20978187.
28. Szczyrba J, Nolte E, Wach S, Kremmer E, Stohr R, Hartmann A, et al. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Molecular cancer research: MCR. 2011; 9(6): 791-800. doi: 10.1158/1541-7786.MCR-10-0573 PMID: 21593139.
29. Wang S, Wang L, Zhu T, Gao X, Li J, Wu Y, et al. Improvement of tissue preparation for laser capture microdissection: Application for cell type-specific miRNA expression profiling in colorectal tumors. BMC genomics. 2010; 11: 163. doi: 10.1186/1471-2164-11-163 PMID: 20219115; PubMed Central PMCID: PMC2853520.
30. Saitoh T, Hirai M, Katoh M. Molecular cloning and characterization of human Frizzled-8 gene on chromosome 10p11.2. International Journal of oncology. 2001; 18(5): 991-6. PMID: 11295046.
31. Lee EH, Chari R, Lam A, Ng RT, Yee J, English J, et al. Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma. Clinical medicine Oncology. 2008; 2008(2): 169-79. PMID: 20401333; PubMed Central PMCID: PMC2855195.
32. Megidish T, Xu JH, Xu CW. Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). The Journal of Biological Chemistry. 2002; 277(10): 8255-9. doi: 10.1074/jbc.C200001200 PMID: 11788578.
33. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer epidemiology, biomarkers & prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008; 17(3): 645-54. doi: 10.1158/1055-9965.EPI-07-2518 PMID: 18349282; PubMed Central PMCID: PMC2798850.
34. Nalaskowski MM, Fliegert R, Ernst O, Brehm MA, Fanick W, Windhorst S, et al. Human inositol 1, 4, 5-trisphosphate 3-kinase isoform B (IP3KB) is a nucleocytoplasmic shuttling protein specifically enriched at cortical actin filaments and at invaginations of the nuclear envelope. The Journal of Biological Chemistry. 2011; 286(6): 4500-10. doi: 10.1074/jbc.M110.173062 PMID: 21148483; PubMed Central PMCID: PMC3039344.
35. Tajouri L, Mellick AS, Tourtellotte A, Nagra RM, Griffiths LR. An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis. Brain research Brain research protocols. 2005; 15(2): 79-91. doi: 10.1016/j. brainresprot.2005.04.003 PMID: 15905117.
36. Kim S, Choi M, Cho KH. Identifying the target mRNAs of microRNAs in colorectal cancer. Computational biology and chemistry. 2009; 33(1): 94-9. doi: 10.1016/j.compbiolchem.2008.07.016 PMID: 18723399.
37. Wang YP, Li KB. Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data. BMC genomics. 2009; 10: 218. doi: 10.1186/1471-2164-10-218 PMID: 19435500; PubMed Central PMCID: PMC2686738.
38. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: MicroRNAs can up-regulate translation. Science. 2007; 318(5858): 1931-4. doi: 10.1126/science.1149460 PMID: 18048652.
39. Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PloS one. 2010; 5 (2): E8898. doi: 10.1371/Journal.pone.0008898 PMID: 20126538; PubMed Central PMCID: PMC2813862.